Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt

We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2007-12, Vol.13 (47), p.6439-6440
Hauptverfasser: Giannarelli, Chiara, De Giorgi, Antonio, De Negri, Ferdinando, Carmassi, Franco
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6440
container_issue 47
container_start_page 6439
container_title World journal of gastroenterology : WJG
container_volume 13
creator Giannarelli, Chiara
De Giorgi, Antonio
De Negri, Ferdinando
Carmassi, Franco
description We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.
doi_str_mv 10.3748/wjg.v13.i47.6439
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>26173623</cqvip_id><sourcerecordid>69075826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3369-6ce8328def8f91b3d92f055281b72d1168e0326561725ef22ebd7ed19e8a81ef3</originalsourceid><addsrcrecordid>eNpVkctv1DAQhy0EokvhzglZHLhl8SOxnQsSanlJlbjA2XKc8cYlsVPb2ar_Pa52xeM0h_nNNzP6EHpNyZ7LVr2_vz3sj5TvfSv3ouX9E7RjjPYNUy15inaUENn0nMkL9CLnW0IY5x17ji6oIooyLncIrsHGZYWQTYERrzGV2KzbvMRg0gOeHlZIpXZ9DNgHbLD1KU2xeItXUzyEgu99mXCZUlyGmH3G0Z0w1hzNjPO0hfISPXNmzvDqXC_Rz8-fflx9bW6-f_l29fGmsZyLvhEWFGdqBKdcTwc-9syRrmOKDpKNlAoFhDPRCSpZB44xGEYJI-1BGUXB8Uv04cRdt2GB0dbzkpn1mvxSv9HReP1_J_hJH-JRt4x0rZAV8O4MSPFug1z04rOFeTYB4pa16InsFBM1SE5Bm2LOCdyfJZToRze6utHVja5u9KObOvLm3-P-Dpxl1MDbM3OK4XDnw0EPxv5yfgbN6s9cVH-_AUtWmvA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69075826</pqid></control><display><type>article</type><title>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Giannarelli, Chiara ; De Giorgi, Antonio ; De Negri, Ferdinando ; Carmassi, Franco</creator><creatorcontrib>Giannarelli, Chiara ; De Giorgi, Antonio ; De Negri, Ferdinando ; Carmassi, Franco</creatorcontrib><description>We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v13.i47.6439</identifier><identifier>PMID: 18081237</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Aged ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive Agents - therapeutic use ; Case Report ; Diet, Sodium-Restricted ; Diuretics - therapeutic use ; Drug Therapy, Combination ; Dyspnea - etiology ; Edema - etiology ; Female ; Fibrinolytic Agents - therapeutic use ; Gastrointestinal Agents - therapeutic use ; Heparin, Low-Molecular-Weight - therapeutic use ; Humans ; Hypertension, Portal - complications ; Hypertension, Portal - drug therapy ; Hypertension, Portal - etiology ; Hypertension, Portal - physiopathology ; Hypertension, Pulmonary - complications ; Hypertension, Pulmonary - drug therapy ; Hypertension, Pulmonary - etiology ; Hypertension, Pulmonary - physiopathology ; Lactulose - therapeutic use ; Liver Cirrhosis - surgery ; Portal Pressure ; Portasystemic Shunt, Surgical - adverse effects ; Spironolactone - therapeutic use ; Treatment Outcome ; Vasodilator Agents - therapeutic use ; Venous Thrombosis - complications ; Venous Thrombosis - drug therapy ; Venous Thrombosis - etiology ; Venous Thrombosis - physiopathology ; 肝硬化 ; 血栓形成 ; 高血压</subject><ispartof>World journal of gastroenterology : WJG, 2007-12, Vol.13 (47), p.6439-6440</ispartof><rights>2007 Baishideng Publishing Group Inc. All rights reserved. 2007</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3369-6ce8328def8f91b3d92f055281b72d1168e0326561725ef22ebd7ed19e8a81ef3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205467/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205467/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18081237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giannarelli, Chiara</creatorcontrib><creatorcontrib>De Giorgi, Antonio</creatorcontrib><creatorcontrib>De Negri, Ferdinando</creatorcontrib><creatorcontrib>Carmassi, Franco</creatorcontrib><title>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.</description><subject>Aged</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Case Report</subject><subject>Diet, Sodium-Restricted</subject><subject>Diuretics - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Dyspnea - etiology</subject><subject>Edema - etiology</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Heparin, Low-Molecular-Weight - therapeutic use</subject><subject>Humans</subject><subject>Hypertension, Portal - complications</subject><subject>Hypertension, Portal - drug therapy</subject><subject>Hypertension, Portal - etiology</subject><subject>Hypertension, Portal - physiopathology</subject><subject>Hypertension, Pulmonary - complications</subject><subject>Hypertension, Pulmonary - drug therapy</subject><subject>Hypertension, Pulmonary - etiology</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Lactulose - therapeutic use</subject><subject>Liver Cirrhosis - surgery</subject><subject>Portal Pressure</subject><subject>Portasystemic Shunt, Surgical - adverse effects</subject><subject>Spironolactone - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Vasodilator Agents - therapeutic use</subject><subject>Venous Thrombosis - complications</subject><subject>Venous Thrombosis - drug therapy</subject><subject>Venous Thrombosis - etiology</subject><subject>Venous Thrombosis - physiopathology</subject><subject>肝硬化</subject><subject>血栓形成</subject><subject>高血压</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctv1DAQhy0EokvhzglZHLhl8SOxnQsSanlJlbjA2XKc8cYlsVPb2ar_Pa52xeM0h_nNNzP6EHpNyZ7LVr2_vz3sj5TvfSv3ouX9E7RjjPYNUy15inaUENn0nMkL9CLnW0IY5x17ji6oIooyLncIrsHGZYWQTYERrzGV2KzbvMRg0gOeHlZIpXZ9DNgHbLD1KU2xeItXUzyEgu99mXCZUlyGmH3G0Z0w1hzNjPO0hfISPXNmzvDqXC_Rz8-fflx9bW6-f_l29fGmsZyLvhEWFGdqBKdcTwc-9syRrmOKDpKNlAoFhDPRCSpZB44xGEYJI-1BGUXB8Uv04cRdt2GB0dbzkpn1mvxSv9HReP1_J_hJH-JRt4x0rZAV8O4MSPFug1z04rOFeTYB4pa16InsFBM1SE5Bm2LOCdyfJZToRze6utHVja5u9KObOvLm3-P-Dpxl1MDbM3OK4XDnw0EPxv5yfgbN6s9cVH-_AUtWmvA</recordid><startdate>20071221</startdate><enddate>20071221</enddate><creator>Giannarelli, Chiara</creator><creator>De Giorgi, Antonio</creator><creator>De Negri, Ferdinando</creator><creator>Carmassi, Franco</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20071221</creationdate><title>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</title><author>Giannarelli, Chiara ; De Giorgi, Antonio ; De Negri, Ferdinando ; Carmassi, Franco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3369-6ce8328def8f91b3d92f055281b72d1168e0326561725ef22ebd7ed19e8a81ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Case Report</topic><topic>Diet, Sodium-Restricted</topic><topic>Diuretics - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Dyspnea - etiology</topic><topic>Edema - etiology</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Heparin, Low-Molecular-Weight - therapeutic use</topic><topic>Humans</topic><topic>Hypertension, Portal - complications</topic><topic>Hypertension, Portal - drug therapy</topic><topic>Hypertension, Portal - etiology</topic><topic>Hypertension, Portal - physiopathology</topic><topic>Hypertension, Pulmonary - complications</topic><topic>Hypertension, Pulmonary - drug therapy</topic><topic>Hypertension, Pulmonary - etiology</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Lactulose - therapeutic use</topic><topic>Liver Cirrhosis - surgery</topic><topic>Portal Pressure</topic><topic>Portasystemic Shunt, Surgical - adverse effects</topic><topic>Spironolactone - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Vasodilator Agents - therapeutic use</topic><topic>Venous Thrombosis - complications</topic><topic>Venous Thrombosis - drug therapy</topic><topic>Venous Thrombosis - etiology</topic><topic>Venous Thrombosis - physiopathology</topic><topic>肝硬化</topic><topic>血栓形成</topic><topic>高血压</topic><toplevel>online_resources</toplevel><creatorcontrib>Giannarelli, Chiara</creatorcontrib><creatorcontrib>De Giorgi, Antonio</creatorcontrib><creatorcontrib>De Negri, Ferdinando</creatorcontrib><creatorcontrib>Carmassi, Franco</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giannarelli, Chiara</au><au>De Giorgi, Antonio</au><au>De Negri, Ferdinando</au><au>Carmassi, Franco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2007-12-21</date><risdate>2007</risdate><volume>13</volume><issue>47</issue><spage>6439</spage><epage>6440</epage><pages>6439-6440</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>18081237</pmid><doi>10.3748/wjg.v13.i47.6439</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2007-12, Vol.13 (47), p.6439-6440
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205467
source MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Aged
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antihypertensive Agents - therapeutic use
Case Report
Diet, Sodium-Restricted
Diuretics - therapeutic use
Drug Therapy, Combination
Dyspnea - etiology
Edema - etiology
Female
Fibrinolytic Agents - therapeutic use
Gastrointestinal Agents - therapeutic use
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Hypertension, Portal - complications
Hypertension, Portal - drug therapy
Hypertension, Portal - etiology
Hypertension, Portal - physiopathology
Hypertension, Pulmonary - complications
Hypertension, Pulmonary - drug therapy
Hypertension, Pulmonary - etiology
Hypertension, Pulmonary - physiopathology
Lactulose - therapeutic use
Liver Cirrhosis - surgery
Portal Pressure
Portasystemic Shunt, Surgical - adverse effects
Spironolactone - therapeutic use
Treatment Outcome
Vasodilator Agents - therapeutic use
Venous Thrombosis - complications
Venous Thrombosis - drug therapy
Venous Thrombosis - etiology
Venous Thrombosis - physiopathology
肝硬化
血栓形成
高血压
title Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A20%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decompensated%20porto-pulmonary%20hypertension%20in%20a%20cirrhotic%20patient%20with%20thrombosis%20of%20portocaval%20shunt&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Giannarelli,%20Chiara&rft.date=2007-12-21&rft.volume=13&rft.issue=47&rft.spage=6439&rft.epage=6440&rft.pages=6439-6440&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v13.i47.6439&rft_dat=%3Cproquest_pubme%3E69075826%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69075826&rft_id=info:pmid/18081237&rft_cqvip_id=26173623&rfr_iscdi=true